Digital tool that personalises antidepressant treatment significantly improves outcomes of people with depression
An AI-driven tool that tailors antidepressant treatment to individual patients was shown to improve outcomes for people with depression, compared to standard treatment, in a major international trial.
Read more
What do we research?
Work with us
Study with us
Latest News
Digital tool that personalises antidepressant treatment significantly improves outcomes of people with depression
4 March 2026
An AI-driven tool that tailors antidepressant treatment to individual patients was shown to improve outcomes for people with depression, compared to standard treatment, in a major international trial.
Targeted TUNE‑UP service boosts access to clozapine for patients - new paper
26 February 2026
A new study examining the impact of an innovative clinic has highlighted its significant impact, showing a dramatic increase in the number of patients able to start clozapine safely in the community.
Potential use for blood biomarkers in dementia diagnosis where medical resources are limited
24 February 2026
Blood biomarkers are highly accessible for use in diagnosis, and there is very strong potential for them to be valuable in low- and middle-income countries (LMICs) where they can be scalable and extend accurate diagnosis.
Talks, discussions, events
Department Seminar Series | Digital Innovation in Metabolic Psychiatry: AI-enabled Ketogenic and GLP-1 - Supported Lifestyle Interventions
Tuesday, 10 March 2026, 9.30am to 10.30am
Departmental facts and figures
NIHR Oxford Health BRC
Find out more about the Oxford Health Biomedical Research Centre (BRC) based in the Department of Psychiatry.